Dilated Cardiomyopathy: Phosphorus 31 MR Spectroscopy at 7 T

Purpose To test whether the increased signal-to-noise ratio of phosphorus 31 ( P) magnetic resonance (MR) spectroscopy at 7 T improves precision in cardiac metabolite quantification in patients with dilated cardiomyopathy (DCM) compared with that at 3 T. Materials and Methods Ethical approval was ob...

Full description

Saved in:
Bibliographic Details
Published inRadiology Vol. 281; no. 2; pp. 409 - 417
Main Authors Stoll, Victoria M., Clarke, William T., Levelt, Eylem, Liu, Alexander, Myerson, Saul G., Robson, Matthew D., Neubauer, Stefan, Rodgers, Christopher T.
Format Journal Article
LanguageEnglish
Published United States Radiological Society of North America 01.11.2016
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Purpose To test whether the increased signal-to-noise ratio of phosphorus 31 ( P) magnetic resonance (MR) spectroscopy at 7 T improves precision in cardiac metabolite quantification in patients with dilated cardiomyopathy (DCM) compared with that at 3 T. Materials and Methods Ethical approval was obtained, and participants provided written informe consent. In a prospective study, P MR spectroscopy was performed at 3 T and 7 T in 25 patients with DCM. Ten healthy matched control subjects underwent P MR spectroscopy at 7 T. Paired Student t tests were performed to compare results between the 3-T and 7-T studies. Results The phosphocreatine (PCr) signal-to-noise ratio increased 2.5 times at 7 T compared with that at 3 T. The PCr to adenosine triphosphate (ATP) concentration ratio (PCr/ATP) was similar at both field strengths (mean ± standard deviation, 1.48 ± 0.44 at 3 T vs 1.54 ± 0.39 at 7 T, P = .49), as expected. The Cramér-Rao lower bounds in PCr concentration (a measure of uncertainty in the measured ratio) were 45% lower at 7 T than at 3 T, reflecting the higher quality of 7-T P spectra. Patients with dilated cardioyopathy had a significantly lower PCr/ATP than did healthy control subjects at 7 T (1.54 ± 0.39 vs 1.95 ± 0.25, P = .005), which is consistent with previous findings. Conclusion 7-T cardiac P MR spectroscopy is feasible in patients with DCM and gives higher signal-to-noise ratios and more precise quantification of the PCr/ATP than that at 3 T. PCr/ATP was significantly lower in patients with DCM than in control subjects at 7 T, which is consistent with previous findings at lower field strengths.
AbstractList Purpose To test whether the increased signal-to-noise ratio of phosphorus 31 ( P) magnetic resonance (MR) spectroscopy at 7 T improves precision in cardiac metabolite quantification in patients with dilated cardiomyopathy (DCM) compared with that at 3 T. Materials and Methods Ethical approval was obtained, and participants provided written informe consent. In a prospective study, P MR spectroscopy was performed at 3 T and 7 T in 25 patients with DCM. Ten healthy matched control subjects underwent P MR spectroscopy at 7 T. Paired Student t tests were performed to compare results between the 3-T and 7-T studies. Results The phosphocreatine (PCr) signal-to-noise ratio increased 2.5 times at 7 T compared with that at 3 T. The PCr to adenosine triphosphate (ATP) concentration ratio (PCr/ATP) was similar at both field strengths (mean ± standard deviation, 1.48 ± 0.44 at 3 T vs 1.54 ± 0.39 at 7 T, P = .49), as expected. The Cramér-Rao lower bounds in PCr concentration (a measure of uncertainty in the measured ratio) were 45% lower at 7 T than at 3 T, reflecting the higher quality of 7-T P spectra. Patients with dilated cardioyopathy had a significantly lower PCr/ATP than did healthy control subjects at 7 T (1.54 ± 0.39 vs 1.95 ± 0.25, P = .005), which is consistent with previous findings. Conclusion 7-T cardiac P MR spectroscopy is feasible in patients with DCM and gives higher signal-to-noise ratios and more precise quantification of the PCr/ATP than that at 3 T. PCr/ATP was significantly lower in patients with DCM than in control subjects at 7 T, which is consistent with previous findings at lower field strengths.
Purpose To test whether the increased signal-to-noise ratio of phosphorus 31 (31P) magnetic resonance (MR) spectroscopy at 7 T improves precision in cardiac metabolite quantification in patients with dilated cardiomyopathy (DCM) compared with that at 3 T. Materials and Methods Ethical approval was obtained, and participants provided written informe consent. In a prospective study, 31P MR spectroscopy was performed at 3 T and 7 T in 25 patients with DCM. Ten healthy matched control subjects underwent 31P MR spectroscopy at 7 T. Paired Student t tests were performed to compare results between the 3-T and 7-T studies. Results The phosphocreatine (PCr) signal-to-noise ratio increased 2.5 times at 7 T compared with that at 3 T. The PCr to adenosine triphosphate (ATP) concentration ratio (PCr/ATP) was similar at both field strengths (mean ± standard deviation, 1.48 ± 0.44 at 3 T vs 1.54 ± 0.39 at 7 T, P = .49), as expected. The Cramér-Rao lower bounds in PCr concentration (a measure of uncertainty in the measured ratio) were 45% lower at 7 T than at 3 T, reflecting the higher quality of 7-T 31P spectra. Patients with dilated cardioyopathy had a significantly lower PCr/ATP than did healthy control subjects at 7 T (1.54 ± 0.39 vs 1.95 ± 0.25, P = .005), which is consistent with previous findings. Conclusion 7-T cardiac 31P MR spectroscopy is feasible in patients with DCM and gives higher signal-to-noise ratios and more precise quantification of the PCr/ATP than that at 3 T. PCr/ATP was significantly lower in patients with DCM than in control subjects at 7 T, which is consistent with previous findings at lower field strengths.Purpose To test whether the increased signal-to-noise ratio of phosphorus 31 (31P) magnetic resonance (MR) spectroscopy at 7 T improves precision in cardiac metabolite quantification in patients with dilated cardiomyopathy (DCM) compared with that at 3 T. Materials and Methods Ethical approval was obtained, and participants provided written informe consent. In a prospective study, 31P MR spectroscopy was performed at 3 T and 7 T in 25 patients with DCM. Ten healthy matched control subjects underwent 31P MR spectroscopy at 7 T. Paired Student t tests were performed to compare results between the 3-T and 7-T studies. Results The phosphocreatine (PCr) signal-to-noise ratio increased 2.5 times at 7 T compared with that at 3 T. The PCr to adenosine triphosphate (ATP) concentration ratio (PCr/ATP) was similar at both field strengths (mean ± standard deviation, 1.48 ± 0.44 at 3 T vs 1.54 ± 0.39 at 7 T, P = .49), as expected. The Cramér-Rao lower bounds in PCr concentration (a measure of uncertainty in the measured ratio) were 45% lower at 7 T than at 3 T, reflecting the higher quality of 7-T 31P spectra. Patients with dilated cardioyopathy had a significantly lower PCr/ATP than did healthy control subjects at 7 T (1.54 ± 0.39 vs 1.95 ± 0.25, P = .005), which is consistent with previous findings. Conclusion 7-T cardiac 31P MR spectroscopy is feasible in patients with DCM and gives higher signal-to-noise ratios and more precise quantification of the PCr/ATP than that at 3 T. PCr/ATP was significantly lower in patients with DCM than in control subjects at 7 T, which is consistent with previous findings at lower field strengths.
Cardiac phosphorus spectroscopy is demonstrated to be feasible in patients at 7 T, giving higher signal-to-noise ratios and more precise quantification of the phosphocreatine to adenosine triphosphate concentration ratio than at 3 T in a group of 25 patients with dilated cardiomyopathy.
Author Stoll, Victoria M.
Levelt, Eylem
Robson, Matthew D.
Neubauer, Stefan
Rodgers, Christopher T.
Clarke, William T.
Liu, Alexander
Myerson, Saul G.
Author_xml – sequence: 1
  givenname: Victoria M.
  surname: Stoll
  fullname: Stoll, Victoria M.
– sequence: 2
  givenname: William T.
  surname: Clarke
  fullname: Clarke, William T.
– sequence: 3
  givenname: Eylem
  surname: Levelt
  fullname: Levelt, Eylem
– sequence: 4
  givenname: Alexander
  surname: Liu
  fullname: Liu, Alexander
– sequence: 5
  givenname: Saul G.
  surname: Myerson
  fullname: Myerson, Saul G.
– sequence: 6
  givenname: Matthew D.
  surname: Robson
  fullname: Robson, Matthew D.
– sequence: 7
  givenname: Stefan
  surname: Neubauer
  fullname: Neubauer, Stefan
– sequence: 8
  givenname: Christopher T.
  orcidid: 0000-0003-1275-1197
  surname: Rodgers
  fullname: Rodgers, Christopher T.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27326664$$D View this record in MEDLINE/PubMed
BookMark eNp1kVtrGzEQhUVJaWwnP6AvZR_zso5G9w0hUNxcCgkJrfMsZEmuFdarrSQH_O-7wUnbBPI0A3POd2DOGO11sfMIfQY8BWDqOBkXYjslGARwIkjzAY2GRdZAge-hEcaU1opBs4_GOT9gDIwr-QntE0mJEIKN0Om30JriXTUzaYCtt7E3ZbU9qe5WMfermDa5olDd_Kh-9t6WFLON_bYypZLV_AB9XJo2-8PnOUH3F-fz2VV9fXv5ffb1ura0aUqtMBem8ZwJoTDj4BawJA12jhLqKXaUc-Wk5Ayc4gqAGmoWg4UwsNYyQyfobMftN4u1d9Z3JZlW9ymsTdrqaIJ-fenCSv-Kj5pjxRrJBsDRMyDF3xufi16HbH3bms7HTdagiJAYN5QP0i__Z_0NeXnZIJA7gR2ekZNfahuKKSE-RYdWA9ZP5ehdOfpfOYMT3jhf4O97_gDxtZHr
CitedBy_id crossref_primary_10_1093_ehjci_jeac121
crossref_primary_10_1002_nbm_4095
crossref_primary_10_1007_s10741_022_10287_x
crossref_primary_10_1002_mrm_28541
crossref_primary_10_1186_s12968_019_0529_4
crossref_primary_10_1002_mrm_28328
crossref_primary_10_1016_j_hfc_2019_02_010
crossref_primary_10_1016_j_ynirp_2022_100121
crossref_primary_10_1002_mrm_26785
crossref_primary_10_22468_cvia_2018_00122
crossref_primary_10_1371_journal_pone_0187153
crossref_primary_10_1016_j_jacc_2019_10_011
crossref_primary_10_3389_fcvm_2021_653648
crossref_primary_10_1002_mrm_30492
crossref_primary_10_1371_journal_pone_0185356
crossref_primary_10_1016_j_pnmrs_2018_06_001
crossref_primary_10_1161_CIRCIMAGING_118_008130
crossref_primary_10_3390_medicina59010174
crossref_primary_10_1002_jmri_27848
crossref_primary_10_1002_mrm_28494
crossref_primary_10_3389_fcvm_2023_1068390
crossref_primary_10_3389_fphys_2017_00939
crossref_primary_10_1002_nbm_4845
crossref_primary_10_1002_mrm_26576
crossref_primary_10_3390_diagnostics12081846
crossref_primary_10_1002_mrm_26357
crossref_primary_10_1017_pcm_2023_24
Cites_doi 10.1093/eurheartj/ehs341
10.1016/0002-8703(91)90527-O
10.1161/CIRCRESAHA.113.300268
10.1161/01.CIR.86.6.1810
10.1161/CIRCIMAGING.113.000559
10.1155/2014/365404
10.1063/1.1719961
10.1186/1475-925X-10-76
10.1073/pnas.0408962102
10.1002/mrm.24922
10.1016/j.ijrobp.2007.11.001
10.1002/nbm.1255
10.1161/01.CIR.96.7.2190
10.1006/jmre.1997.1244
10.1093/eurheartj/16.suppl_O.115
10.1002/mrm.22230
10.1186/1532-429X-17-S1-P248
10.1186/1532-429X-12-67
10.1002/mrm.1910280106
10.1007/s10554-009-9492-8
10.1016/0002-8703(92)90986-6
10.3109/10976640009148684
10.1002/nbm.701
10.1164/ajrccm.166.1.at1102
10.1002/nbm.1350
10.1007/BF02634597
ContentType Journal Article
Copyright 2016 by the Radiological Society of North America, Inc. 2016
Copyright_xml – notice: 2016 by the Radiological Society of North America, Inc. 2016
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1148/radiol.2016152629
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1527-1315
EndPage 417
ExternalDocumentID PMC5084974
27326664
10_1148_radiol_2016152629
Genre Journal Article
GrantInformation_xml – fundername: Wellcome Trust
– fundername: British Heart Foundation
  grantid: FS/12/14/29354
– fundername: British Heart Foundation
  grantid: FS/15/11/31233
– fundername: Medical Research Council
  grantid: G0900883
– fundername: ; ;
– fundername: ; ;
  grantid: 098436/Z/12/Z
– fundername: ; ;
  grantid: FS/12/14/29354
GroupedDBID ---
.55
.GJ
123
18M
1CY
1KJ
29P
2WC
34G
39C
4.4
53G
5RE
6NX
6PF
7FM
AAEJM
AAQQT
AAWTL
AAYXX
ABDPE
ABHFT
ABOCM
ACFQH
ACGFO
ACJAN
ADBBV
AENEX
AENYM
AFFNX
AFOSN
AJJEV
AJWWR
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CITATION
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
F9R
GX1
H13
J5H
KO8
L7B
LMP
LSO
MJL
MV1
N4W
OK1
P2P
R.V
RKKAF
RXW
SJN
TAE
TR2
TRS
TWZ
W8F
WH7
WOQ
X7M
YQI
YQJ
ZGI
ZVN
ZXP
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c399t-8056a9e546680451db1f290dd323e30d3558d77541d858113a3ab56a241ccc4a3
ISSN 0033-8419
1527-1315
IngestDate Thu Aug 21 18:18:33 EDT 2025
Fri Jul 11 11:59:30 EDT 2025
Sat May 31 02:09:09 EDT 2025
Tue Jul 01 03:21:49 EDT 2025
Thu Apr 24 23:12:51 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
License Published under a CC BY 4.0 license.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c399t-8056a9e546680451db1f290dd323e30d3558d77541d858113a3ab56a241ccc4a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Author contributions: Guarantors of integrity of entire study, V.M.S., S.N., C.T.R.; study concepts/study design or data acquisition or data analysis/interpretation, all authors; manuscript drafting or manuscript revision for important intellectual content, all authors; approval of final version of submitted manuscript, all authors; agrees to ensure any questions related to the work are appropriately resolved, all authors; literature research, V.M.S., M.D.R., S.N., C.T.R.; clinical studies, V.M.S., W.T.C., E.L., A.L., S.G.M., S.N.; experimental studies, V.M.S., W.T.C., C.T.R.; statistical analysis, V.M.S., W.T.C., S.N.; and manuscript editing, V.M.S., E.L., A.L., S.G.M., M.D.R., S.N., C.T.R.
ORCID 0000-0003-1275-1197
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC5084974
PMID 27326664
PQID 1826700935
PQPubID 23479
PageCount 9
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5084974
proquest_miscellaneous_1826700935
pubmed_primary_27326664
crossref_citationtrail_10_1148_radiol_2016152629
crossref_primary_10_1148_radiol_2016152629
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2016-11-01
PublicationDateYYYYMMDD 2016-11-01
PublicationDate_xml – month: 11
  year: 2016
  text: 2016-11-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Radiology
PublicationTitleAlternate Radiology
PublicationYear 2016
Publisher Radiological Society of North America
Publisher_xml – name: Radiological Society of North America
References r2
r3
r4
r5
r6
r7
r8
r9
r10
r31
DelaBarre L (r30) 2015
r14
r13
r16
r15
r18
r17
r19
Rodgers CT (r11) 2014
r21
r20
r23
r22
r25
r27
r26
r29
r28
Rodgers CT (r12) 2010
Bottomley PA (r24) 2009
r1
References_xml – ident: r20
  doi: 10.1093/eurheartj/ehs341
– start-page: 3152
  volume-title: Proceedings of the Twenty-Third Meeting of the International Society for Magnetic Resonance in Medicine
  year: 2015
  ident: r30
– ident: r26
  doi: 10.1016/0002-8703(91)90527-O
– ident: r1
  doi: 10.1161/CIRCRESAHA.113.300268
– ident: r7
  doi: 10.1161/01.CIR.86.6.1810
– ident: r23
  doi: 10.1161/CIRCIMAGING.113.000559
– ident: r2
  doi: 10.1155/2014/365404
– ident: r17
  doi: 10.1063/1.1719961
– ident: r21
  doi: 10.1186/1475-925X-10-76
– ident: r27
  doi: 10.1073/pnas.0408962102
– ident: r8
  doi: 10.1002/mrm.24922
– ident: r31
  doi: 10.1016/j.ijrobp.2007.11.001
– ident: r3
  doi: 10.1002/nbm.1255
– start-page: 1327
  volume-title: Proceedings of the Eighteenth Meeting of the International Society for Magnetic Resonance in Medicine
  year: 2010
  ident: r12
– ident: r25
  doi: 10.1161/01.CIR.96.7.2190
– ident: r15
  doi: 10.1006/jmre.1997.1244
– ident: r6
  doi: 10.1093/eurheartj/16.suppl_O.115
– ident: r18
– ident: r28
  doi: 10.1002/mrm.22230
– ident: r13
  doi: 10.1186/1532-429X-17-S1-P248
– ident: r14
  doi: 10.1186/1532-429X-12-67
– ident: r29
  doi: 10.1002/mrm.1910280106
– volume-title: Encyclopedia of magnetic resonance
  year: 2009
  ident: r24
– ident: r4
  doi: 10.1007/s10554-009-9492-8
– ident: r9
  doi: 10.1016/0002-8703(92)90986-6
– ident: r16
  doi: 10.3109/10976640009148684
– ident: r19
  doi: 10.1002/nbm.701
– start-page: 2896
  volume-title: Proceedings of the Twenty-Second Meeting of the International Society for Magnetic Resonance in Medicine
  year: 2014
  ident: r11
– ident: r10
  doi: 10.1164/ajrccm.166.1.at1102
– ident: r5
  doi: 10.1002/nbm.1350
– ident: r22
  doi: 10.1007/BF02634597
SSID ssj0014587
Score 2.3716836
Snippet Purpose To test whether the increased signal-to-noise ratio of phosphorus 31 ( P) magnetic resonance (MR) spectroscopy at 7 T improves precision in cardiac...
Purpose To test whether the increased signal-to-noise ratio of phosphorus 31 (31P) magnetic resonance (MR) spectroscopy at 7 T improves precision in cardiac...
Cardiac phosphorus spectroscopy is demonstrated to be feasible in patients at 7 T, giving higher signal-to-noise ratios and more precise quantification of the...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 409
SubjectTerms Biomarkers - metabolism
Cardiomyopathy, Dilated - diagnostic imaging
Case-Control Studies
Female
Humans
Magnetic Resonance Spectroscopy - methods
Male
Middle Aged
Original Research
Phosphocreatine - metabolism
Phosphorus
Prospective Studies
Signal-To-Noise Ratio
Title Dilated Cardiomyopathy: Phosphorus 31 MR Spectroscopy at 7 T
URI https://www.ncbi.nlm.nih.gov/pubmed/27326664
https://www.proquest.com/docview/1826700935
https://pubmed.ncbi.nlm.nih.gov/PMC5084974
Volume 281
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF5BkRAXxLtpARmJE5VL9mkHcUElVYGkoOKg3Kxde6NYCnaUOIfw65ldb_ygESpcLGtje52d8eib2ZlvEHodJFwLnmh_wFXqM6a5H1KlfUu1gkkQYGXiHeNLcTFhn6d82nQqtNUlpTpNfu2tK_kfqcIYyNVUyf6DZOuHwgCcg3zhCBKG441k_DFbSIMYz2xS6c9tYfoLWwqnb_NivZwXq836hOKT8ZXtM18a5spiuTUFjIHLjt5xc8s06wTYv5dFtSHxIzNh_Uw2YdMmpccFa5pE65FJQbJmfbhduKCwGc42nWKadqgBC1dz17KOJPAxreovT_WeMWdSSYhbukNaBpJZMoQ9hpuZYoSV_bMm4Q6AFhEuFtIhyb78Gp9PRqM4Gk6j2-gOaFPlSX_6Um8eMW77ItZv5jazYYq31ybowpFrPsafqbIt7BE9QPed0-B9qDTgIbql80fo7tilRTxG750ieF1FeOc1auBR7I2vvLYaeLL0Ai96gibnw-jswndtMfwE0GQJmIILOdCcCREadqBU4RkZ9NOUEqppPzWE-akhNsRpyEOMqaRSwS2A1ZIkYZI-RQd5ketD5IWSEAUePJkJcCsVlTMlSZ_NgoFiBAvRQ_3d6sSJ44w3rUsWcVXPHsbVgsbNgvbQm_qWZUWY8reLX-2WPAazZvaqZK6LzTo2bm9gwm28h55VIqgfB4gbYKVgPRR0hFNfYCjTu7_k2dxSp4M7wsCDPrrBvMfoXvMNPEcH5WqjXwAALdVLq26_AaaRgxw
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Dilated+Cardiomyopathy%3A+Phosphorus+31+MR+Spectroscopy+at+7+T&rft.jtitle=Radiology&rft.au=Stoll%2C+Victoria+M&rft.au=Clarke%2C+William+T&rft.au=Levelt%2C+Eylem&rft.au=Liu%2C+Alexander&rft.date=2016-11-01&rft.issn=1527-1315&rft.eissn=1527-1315&rft.volume=281&rft.issue=2&rft.spage=409&rft_id=info:doi/10.1148%2Fradiol.2016152629&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0033-8419&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0033-8419&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0033-8419&client=summon